Skip to search formSkip to main contentSkip to account menu

MCC 135

Known as: MCC-135, MCC135 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (2)

BenzenesulfonatesPiperazines
caldaret

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Effect of caldaret on the incidence of severe left ventricular dysfunction in patients with ST-elevation myocardial infarction undergoing primary coronary intervention.
2008
2008
Abstract 2665: Reduction in Frequency of Left Ventricular Dysfunction in Patients with ST Elevation Myocardial Infarction Undergoing PCI Treated with Caldaret (MCC-135)
2005
2005
MCC-135 diminishes the egress of CK-MB but not of troponin-I from cardiomyocytes during reperfusion.
2004
2004
A phase II, double-blind, randomized, placebo-controlled, dose comparative study of the efficacy, tolerability, and safety of MCC-135 in subjects with chronic heart failure, NYHA class II/III (MCC…
2003
2003
Effects of MCC-135 on Ca2+ uptake by sarcoplasmic reticulum and myofilament sensitivity to Ca2+ in isolated ventricular muscles of rats with diabetic cardiomyopathy
Diabetic cardiomyopathy is characterized by delayed cardiac relaxation. Delayed relaxation is suggested to be associated with… 
2001
2001
Lusitropic effect of MCC-135 is associated with improvement of sarcoplasmic reticulum function in ventricular muscles of diabetic rats
1999
1999
Positive lusitropic action of MCC-135, a new Ca2+-handling modulator, is associated with modified Ca2+-uptake by sarcoplasmic reticulum and Ca2+ sensitivity of cardiac myofilaments
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)